TORONTO, ONTARIO – December 4, 2020 – OB Pharmaceuticals, Inc., announced today the company will present its poster on its … Read More
LONDON, ONTARIO February 25, 2020 — OB Pharmaceuticals announces the addition of two new members to its Scientific and Clinical … Read More
LONDON, ONTARIO May 16, 2019 — OB Pharmaceuticals CSO, Dr. Michael Poulter in the News. Dr. Michael Poulter, CSO was … Read More
LONDON, ONTARIO January 12, 2019 — Dr. Larry Mahan, CEO of OB Pharmaceuticals, attended the JP Morgan Healthcare Conference week … Read More
LONDON, ONTARIO October 2, 2018 — OB Pharmaceuticals has been granted utility patent US 10,087,138 from the U.S. Patent and … Read More
LONDON, ONTARIO May 2, 2018 — OB Pharmaceuticals was invited to present the details of its drug development program of … Read More
LONDON, ONTARIO January 2, 2018 — Dr. Larry Mahan attended BioTech Showcase 2018 during JP Morgan week in San Francisco … Read More
LONDON, ONTARIO March 10, 2017 — Representatives from OB Pharmaceuticals attended BioEurope Spring 2017 in Barcelona, Spain, March 20-22 to … Read More